BGI Genomics enhances NIFTY prenatal testing kit with DNBSEQ-G99 platform for faster and accurate results

BGI Europe A/S, a wholly owned subsidiary of BGI Genomics, announced its NIFTY non-invasive prenatal testing kit and software (CE-IVDD List B) were granted an extension under its existing CE-IVDD certification to include the DNBSEQ-G99 model to meet the European Union regulations for medical devices.

University of Houston clinic expands to offer eye care to homeless patients

On any given Monday or Thursday in downtown Houston, inside the University of Houston nurse-managed clinic, you can catch a glimpse of why nursing is

October 19, 2023

Pelago Secures $58M to Expand Substance Use Management as an Employee Benefit

What You Should Know: Pelago the leading digital clinic partner to U.S. businesses and health plans for substance use management, today announced $58 million in new

March 29, 2024

Research reveals new insights into the role of efferocytosis in pancreatic cancer liver metastasis

A research paper published today (14 February 2024) in Nature Cancer details new insights into the role of efferocytosis – the burying of dead cells

February 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.